-
Innovation Ranking
NewInnovation Ranking – Chembio Diagnostic Inc
Chembio Diagnostic Inc (Chembio) develops, manufactures, markets and licenses point-of-care diagnostic (POCs) tests for the detection of infectious diseases including COVID-19, sexually transmitted disease, and fever and tropical disease. The company offers products to prevent the spread of infectious diseases with solutions like Dual Path Platform (DPP). Its DPP technology is used to treat infectious diseases such as HIV, Ebola, syphilis, Zika, malaria and febrile illness. Chembio also offers veterinary diagnostics. The company offers products to medical laboratories and hospitals,...
-
Product Insights
Human Immunodeficiency Virus (HIV) Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
HIV Tests Pipeline Market Report Overview Human Immunodeficiency Virus (HIV) tests refer to the antigens, antibodies, and nucleic acid reagent tests performed for the detection of HIV type I. The HIV Tests pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated...
-
Company Profile
Chembio Diagnostic Inc – Company Profile
Chembio Diagnostic Inc (Chembio) develops, manufactures, markets and licenses point-of-care diagnostic (POCs) tests for the detection of infectious diseases including COVID-19, sexually transmitted disease, and fever and tropical disease. The company offers products to prevent the spread of infectious diseases with solutions includes Dual Path Platform (DPP). Its DPP technology is used to treat infectious diseases such as HIV, Ebola, syphilis, Zika, malaria and febrile illness. Chembio also offers veterinary diagnostics. The company offers products to medical laboratories and hospitals,...
Add to Basket -
Product Insights
NewChembio Diagnostic Systems Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Chembio Diagnostic Systems Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Chembio is a leading point-of-care diagnostics company focused on detecting and diagnosing infectious diseases, including COVID-19, sexually transmitted disease, and fever, and tropical disease. The company is headquartered in Medford, New York, United States. GlobalData's Medical Devices company profile report, “Chembio Diagnostic Systems Inc Pipeline Insight and Competitive Landscape, 2023" provides information about the company overview and analysis...
-
Product Insights
Respiratory Disease Tests – Chembio Diagnostics, Inc – DPP
GlobalData, the industry analysis specialist, has released its latest report: Respiratory Disease Tests - Chembio Diagnostics, Inc - DPP. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted by...
-
Product Insights
COVID-19 Tests – Chembio Diagnostics, Inc – DPP
GlobalData, the industry analysis specialist, has released its latest report: COVID-19 Tests - Chembio Diagnostics, Inc - DPP. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted by the...
-
Product Insights
Immunochemistry Rapid Tests and POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Spot test kits intended generally for rapid diagnosis, with immediate results, through immuno assays. Some of the tests carried out using immunochemistry rapid test include rabies virus test, allergenic food proteins, and enteric infection. The immunochemistry rapid tests and POC pipeline market research report provides comprehensive information about the immunochemistry rapid tests and POC pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Sector Analysis
Point-of-Care Diagnostics Market Size, Share, Trends, Analysis and Forecast by Region, Segment, Product (Glucose Monitoring Products, Infectious Disease Testing Products) and Platform (Lateral Flow Assays, Immunoassays), 2022-2027
The point-of-care diagnostics market size was valued at US$36.99 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 11.92% during 2022-2027. The key to the growth has been the high prevalence of infectious diseases and growing investment and funding for product development. Additionally, key strategic partnerships and mergers and acquisitions are expected to accelerate market growth. Over the forecast period, the market will witness an increase in government initiatives, favoring the point-of-care diagnostics...
-
Product Insights
Bacteriology Rapid Tests and POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Bacteriology Rapid Tests & POC comprises rapid test kits intended for rapid diagnosis, with immediate results, through immuno assays for Chlamydia, H. pylori, Streptococci, and Syphilis. The Bacteriology Rapid Tests & POC pipeline market research report provides comprehensive information about the Bacteriology Rapid Tests & POC pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Product Insights
COVID 19 point of care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021
COVID-19 point of care (POC) tests are used to detect the presence or activity of COVID-19 antigen. This segment includes rapid tests and point of care tests for COVID-19. The COVID-19 POC tests pipeline products report provides comprehensive information about the COVID 19 point of care tests pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The report also provides information on the pipeline products...